LAURA MAIER: Open Payments
NPI 1366159394 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,322 in 78 payments from 18 companies in 2025. Trend: 2023 $1,682 · 2024 $1,891 · 2025 $2,322
Food & beverage: $2,322
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $515 |
| E.R. Squibb & Sons, L.L.C. | 11 | $339 |
| ABBVIE INC. | 13 | $300 |
| Alkermes, Inc. | 5 | $251 |
| Axsome Therapeutics, Inc. | 6 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $208 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
Products named: REXULTI, COBENFY, VRAYLAR, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, LYBALVI.
Industry payments across IL — which companies pay providers there.
